Buyer: Fondaparinux sodium usp / intermediates ( n 4, n 3), ropivacaine hcl (usdmf no. 20249 us fda approval), propofol ( api and technology transfer) china gmp, droperidol china gmp, nicorandil china gmp, doxapram hcl china gmp, diatrizoic acid china gmp, meglumine china gmp, formulations/china, injections:, fondarinux sodium injection 2.5 mg/0.5 ml, pfs, propofol injections 1%, 2% 10, 20, 50 ml, ropivacaine mesylate injection, sodium hyaluronate injection, calcium gluconate injections, mct/lct fat emulsion injection, doxapram hcl injection, diatrizoate meglumine and diatrizoate sodium injection, tablets and capsules:, 1. nicorandil tablets, 5 mg, 2. amlopdipine besylate tablets, 5 mg, 3. fenofibrate micronized capsules, 4. lecitin bound iodine capsules, non alcohol hand sanitizer us fda
